The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Stem Cell Manufacturing-Global Market Insights and Sales Trends 2024
Synopsis
Large-scale manufacturing of human stem cells for therapeutic use is a leap in technology and science for the current biotechnology industry.
The global Stem Cell Manufacturing market size is expected to reach US$ 16930 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Stem Cell Manufacturing in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Companies, Cell Banks and Tissue Banks and Others,, are propelling Stem Cell Manufacturing market. Product, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Stem Cell Manufacturing market, driven by demand from China, the second largest economy with some signs of stabilising, the Stem Cell Manufacturing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stem Cell Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stem Cell Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stem Cell Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stem Cell Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stem Cell Manufacturing covered in this report include Thermo Fisher, Merck Group, Becton Dickinson, Bio-Rad, Miltenyi Biotec, Takara Bio, STEMCELL, Pharmicell and Osiris, etc.
The global Stem Cell Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Merck Group
Becton Dickinson
Bio-Rad
Miltenyi Biotec
Takara Bio
STEMCELL
Pharmicell
Osiris
Anterogen
Cellular Dynamics
MEDIPOST
Lonza
Holostem
Pluristem
Global Stem Cell Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stem Cell Manufacturing market, Segment by Type:
Product
Services
Global Stem Cell Manufacturing market, by Application
Pharmaceutical and Biotechnology Companies
Cell Banks and Tissue Banks
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stem Cell Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Large-scale manufacturing of human stem cells for therapeutic use is a leap in technology and science for the current biotechnology industry.
The global Stem Cell Manufacturing market size is expected to reach US$ 16930 million by 2029, growing at a CAGR of 4.3% from 2023 to 2029. The market is mainly driven by the significant applications of Stem Cell Manufacturing in various end use industries. The expanding demands from the Pharmaceutical and Biotechnology Companies, Cell Banks and Tissue Banks and Others,, are propelling Stem Cell Manufacturing market. Product, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Services segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Stem Cell Manufacturing market, driven by demand from China, the second largest economy with some signs of stabilising, the Stem Cell Manufacturing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Stem Cell Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Stem Cell Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Stem Cell Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Stem Cell Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Stem Cell Manufacturing covered in this report include Thermo Fisher, Merck Group, Becton Dickinson, Bio-Rad, Miltenyi Biotec, Takara Bio, STEMCELL, Pharmicell and Osiris, etc.
The global Stem Cell Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher
Merck Group
Becton Dickinson
Bio-Rad
Miltenyi Biotec
Takara Bio
STEMCELL
Pharmicell
Osiris
Anterogen
Cellular Dynamics
MEDIPOST
Lonza
Holostem
Pluristem
Global Stem Cell Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Stem Cell Manufacturing market, Segment by Type:
Product
Services
Global Stem Cell Manufacturing market, by Application
Pharmaceutical and Biotechnology Companies
Cell Banks and Tissue Banks
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Stem Cell Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Stem Cell Manufacturing
1.1 Stem Cell Manufacturing Market Overview
1.1.1 Stem Cell Manufacturing Product Scope
1.1.2 Stem Cell Manufacturing Market Status and Outlook
1.2 Global Stem Cell Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Stem Cell Manufacturing Market Size by Region (2018-2029)
1.4 Global Stem Cell Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Stem Cell Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Stem Cell Manufacturing Market Size (2018-2029)
1.6.1 North America Stem Cell Manufacturing Market Size (2018-2029)
1.6.2 Europe Stem Cell Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Stem Cell Manufacturing Market Size (2018-2029)
1.6.4 Latin America Stem Cell Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Stem Cell Manufacturing Market Size (2018-2029)
2 Stem Cell Manufacturing Market by Type
2.1 Introduction
2.1.1 Product
2.1.2 Services
2.2 Global Stem Cell Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Stem Cell Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Stem Cell Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Stem Cell Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Stem Cell Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Stem Cell Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Stem Cell Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Stem Cell Manufacturing Revenue Breakdown by Type (2018-2029)
3 Stem Cell Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical and Biotechnology Companies
3.1.2 Cell Banks and Tissue Banks
3.1.3 Others
3.2 Global Stem Cell Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Stem Cell Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Stem Cell Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Stem Cell Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Stem Cell Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Stem Cell Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Stem Cell Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Stem Cell Manufacturing Revenue Breakdown by Application (2018-2029)
4 Stem Cell Manufacturing Competition Analysis by Players
4.1 Global Stem Cell Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Stem Cell Manufacturing as of 2022)
4.3 Date of Key Players Enter into Stem Cell Manufacturing Market
4.4 Global Top Players Stem Cell Manufacturing Headquarters and Area Served
4.5 Key Players Stem Cell Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Stem Cell Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher
5.1.1 Thermo Fisher Profile
5.1.2 Thermo Fisher Main Business
5.1.3 Thermo Fisher Stem Cell Manufacturing Products, Services and Solutions
5.1.4 Thermo Fisher Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Recent Developments
5.2 Merck Group
5.2.1 Merck Group Profile
5.2.2 Merck Group Main Business
5.2.3 Merck Group Stem Cell Manufacturing Products, Services and Solutions
5.2.4 Merck Group Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Group Recent Developments
5.3 Becton Dickinson
5.3.1 Becton Dickinson Profile
5.3.2 Becton Dickinson Main Business
5.3.3 Becton Dickinson Stem Cell Manufacturing Products, Services and Solutions
5.3.4 Becton Dickinson Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Recent Developments
5.4 Bio-Rad
5.4.1 Bio-Rad Profile
5.4.2 Bio-Rad Main Business
5.4.3 Bio-Rad Stem Cell Manufacturing Products, Services and Solutions
5.4.4 Bio-Rad Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Recent Developments
5.5 Miltenyi Biotec
5.5.1 Miltenyi Biotec Profile
5.5.2 Miltenyi Biotec Main Business
5.5.3 Miltenyi Biotec Stem Cell Manufacturing Products, Services and Solutions
5.5.4 Miltenyi Biotec Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 Miltenyi Biotec Recent Developments
5.6 Takara Bio
5.6.1 Takara Bio Profile
5.6.2 Takara Bio Main Business
5.6.3 Takara Bio Stem Cell Manufacturing Products, Services and Solutions
5.6.4 Takara Bio Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 Takara Bio Recent Developments
5.7 STEMCELL
5.7.1 STEMCELL Profile
5.7.2 STEMCELL Main Business
5.7.3 STEMCELL Stem Cell Manufacturing Products, Services and Solutions
5.7.4 STEMCELL Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 STEMCELL Recent Developments
5.8 Pharmicell
5.8.1 Pharmicell Profile
5.8.2 Pharmicell Main Business
5.8.3 Pharmicell Stem Cell Manufacturing Products, Services and Solutions
5.8.4 Pharmicell Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 Pharmicell Recent Developments
5.9 Osiris
5.9.1 Osiris Profile
5.9.2 Osiris Main Business
5.9.3 Osiris Stem Cell Manufacturing Products, Services and Solutions
5.9.4 Osiris Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Osiris Recent Developments
5.10 Anterogen
5.10.1 Anterogen Profile
5.10.2 Anterogen Main Business
5.10.3 Anterogen Stem Cell Manufacturing Products, Services and Solutions
5.10.4 Anterogen Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 Anterogen Recent Developments
5.11 Cellular Dynamics
5.11.1 Cellular Dynamics Profile
5.11.2 Cellular Dynamics Main Business
5.11.3 Cellular Dynamics Stem Cell Manufacturing Products, Services and Solutions
5.11.4 Cellular Dynamics Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Cellular Dynamics Recent Developments
5.12 MEDIPOST
5.12.1 MEDIPOST Profile
5.12.2 MEDIPOST Main Business
5.12.3 MEDIPOST Stem Cell Manufacturing Products, Services and Solutions
5.12.4 MEDIPOST Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.12.5 MEDIPOST Recent Developments
5.13 Lonza
5.13.1 Lonza Profile
5.13.2 Lonza Main Business
5.13.3 Lonza Stem Cell Manufacturing Products, Services and Solutions
5.13.4 Lonza Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.13.5 Lonza Recent Developments
5.14 Holostem
5.14.1 Holostem Profile
5.14.2 Holostem Main Business
5.14.3 Holostem Stem Cell Manufacturing Products, Services and Solutions
5.14.4 Holostem Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.14.5 Holostem Recent Developments
5.15 Pluristem
5.15.1 Pluristem Profile
5.15.2 Pluristem Main Business
5.15.3 Pluristem Stem Cell Manufacturing Products, Services and Solutions
5.15.4 Pluristem Stem Cell Manufacturing Revenue (US$ Million) & (2018-2023)
5.15.5 Pluristem Recent Developments
6 North America
6.1 North America Stem Cell Manufacturing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Stem Cell Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Stem Cell Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Stem Cell Manufacturing Market Dynamics
11.1 Stem Cell Manufacturing Industry Trends
11.2 Stem Cell Manufacturing Market Drivers
11.3 Stem Cell Manufacturing Market Challenges
11.4 Stem Cell Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
